EFPIA：2025年通过标准化和产品碳足迹评估的统一来推进药品环境可持续性评估报告（英文版）

The innovative pharmaceutical industry as represented by the European Federation of Pharmaceutical Industries and Associations (EFPIA) is committed to climate action and further environmental sustainability aspects.1 Increasingly, policymakers, healthcare systems, buyers, and the wider society are calling for transparent, product-level environmental information, primarily Product Carbon Footprints (PCF), as the expectation for granular data grows across all industries.